Literature DB >> 23977499

Transcatheter resection of the native aortic valve prior to endovalve implantation - A rational approach to reduce TAVI-induced complications.

Parla Astarci1, Pierre-Yves Etienne, Benoit Raucent, Xavier Bollen, Kahn Tranduy, David Glineur, Laurent Dekerchove, Philippe Noirhomme, Gébrine Elkhoury.   

Abstract

Year:  2012        PMID： 23977499      PMCID： PMC3741734          DOI： 10.3978/j.issn.2225-319X.2012.06.15

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  45 in total

1.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Kanu Chatterjee; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-08-01       Impact factor: 24.094

Review 2.  Central nervous system injury associated with cardiac surgery.

Authors:  Mark F Newman; Joseph P Mathew; Hilary P Grocott; G Burkhard Mackensen; Terri Monk; Kathleen A Welsh-Bohmer; James A Blumenthal; Daniel T Laskowitz; Daniel B Mark
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

3.  Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

Authors:  Alec Vahanian; Helmut Baumgartner; Jeroen Bax; Eric Butchart; Robert Dion; Gerasimos Filippatos; Frank Flachskampf; Roger Hall; Bernard Iung; Jaroslaw Kasprzak; Patrick Nataf; Pilar Tornos; Lucia Torracca; Arnold Wenink
Journal:  Eur Heart J       Date:  2007-01-26       Impact factor: 29.983

4.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

5.  Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis.

Authors:  Corrado Tamburino; Davide Capodanno; Angelo Ramondo; Anna Sonia Petronio; Federica Ettori; Gennaro Santoro; Silvio Klugmann; Francesco Bedogni; Francesco Maisano; Antonio Marzocchi; Arnaldo Poli; David Antoniucci; Massimo Napodano; Marco De Carlo; Claudia Fiorina; Gian Paolo Ussia
Journal:  Circulation       Date:  2011-01-10       Impact factor: 29.690

6.  Transcatheter aortic valve implantation: first results from a multi-centre real-world registry.

Authors:  Ralf Zahn; Ulrich Gerckens; Eberhard Grube; Axel Linke; Horst Sievert; Holger Eggebrecht; Rainer Hambrecht; Stefan Sack; Karl Eugen Hauptmann; Gert Richardt; Hans-Reiner Figulla; Jochen Senges
Journal:  Eur Heart J       Date:  2010-09-23       Impact factor: 29.983

7.  Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.

Authors:  Martyn Thomas; Gerhard Schymik; Thomas Walther; Dominique Himbert; Thierry Lefèvre; Hendrik Treede; Holger Eggebrecht; Paolo Rubino; Iassen Michev; Rüdiger Lange; William N Anderson; Olaf Wendler
Journal:  Circulation       Date:  2010-06-21       Impact factor: 29.690

8.  Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.

Authors:  Cosmo Godino; Francesco Maisano; Matteo Montorfano; Azeem Latib; Alaide Chieffo; Iassen Michev; Rasha Al-Lamee; Marta Bande; Marco Mussardo; Francesco Arioli; Alfonso Ielasi; Micaela Cioni; Maurizio Taramasso; Irina Arendar; Antonio Grimaldi; Pietro Spagnolo; Alberto Zangrillo; Giovanni La Canna; Ottavio Alfieri; Antonio Colombo
Journal:  JACC Cardiovasc Interv       Date:  2010-11       Impact factor: 11.195

9.  Impact of patient-prosthesis mismatch and aortic valve design on coronary flow reserve after aortic valve replacement.

Authors:  Farhad Bakhtiary; Mirko Schiemann; Omer Dzemali; Selami Dogan; Volker Schächinger; Hans Ackermann; Anton Moritz; Peter Kleine
Journal:  J Am Coll Cardiol       Date:  2007-02-05       Impact factor: 24.094

10.  Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis.

Authors:  Marie-Annick Clavel; John G Webb; Philippe Pibarot; Lukas Altwegg; Eric Dumont; Chris Thompson; Robert De Larochellière; Daniel Doyle; Jean-Bernard Masson; Sebastien Bergeron; Olivier F Bertrand; Josep Rodés-Cabau
Journal:  J Am Coll Cardiol       Date:  2009-05-19       Impact factor: 24.094
View more
  2 in total

1.  Thrombogenic potential of transcatheter aortic valve implantation with trivial paravalvular leakage.

Authors:  Lawrence N Scotten; Rolland Siegel
Journal:  Ann Transl Med       Date:  2014-05

2.  Mid-term follow-up after suture-less aortic heart valve implantation.

Authors:  Grzegorz Filip; Radoslaw Litwinowicz; Boguslaw Kapelak; Jacek Piatek; Magdalena Bartus; Janusz Konstanty-Kalandyk; Maciej Brzezinski; Krzysztof Bartus
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.